Breaking News Instant updates and real-time market news.

BFST

Business First Bancshares

$21.01 /

-0.235 (-1.11%)

16:04
01/25/21
01/25
16:04
01/25/21
16:04

Business First Bancshares reports Q4 EPS 68c, consensus 50c

For the quarter ended December 31, 2020, net interest income totaled $39.6 million and net interest margin and net interest spread were 4.26% and 4.03%, respectively, compared to compared to $20.6 million, 4.08% and 3.65% for the quarter ended December 31, 2019. The average yield on the loan portfolio (excluding SBA PPP loans) was 5.59% for the quarter ended December 31, 2020, compared to 5.82% for the quarter ended December 31, 2019. The average yield on total interest-earning assets was 4.78% for the quarter ended December 31, 2020, compared to 5.28% for the quarter ended December 31, 2019. The increase in interest income was largely attributable to higher average balances due to the Pedestal acquisition and origination of SBA PPP loans during 2020. "We finished the year right where we set out to last spring, though we never imagined the path we would all take to get here," said Jude Melville, president and CEO. "b1BANK's core earnings power reflects our increasing scale and improving efficiency, our asset quality is stable and our balance sheet is as liquid as it's ever been. Our people were called upon to process PPP loans, originate and close Main Street Lending Program relationships, and integrate a significant acquisition, all while being tested by COVID-19 and two hurricanes. Not only did they respond, they responded with confidence and pride. Never before has our team been as proud to be community bankers and never before have I been as proud to be a part of their team."

  • 02

    Feb

BFST Business First Bancshares
$21.01 /

-0.235 (-1.11%)

05/01/20 DA Davidson
Business First Bancshares downgraded to Neutral from Buy at DA Davidson
05/01/20 DA Davidson
Business First Bancshares downgraded to Neutral from Buy at DA Davidson
04/29/20 Raymond James
Business First Bancshares double downgraded to Market Perform at Raymond James
04/29/20 Raymond James
Business First Bancshares downgraded to Market Perform at Raymond James

TODAY'S FREE FLY STORIES

Recommendations
Biogen price target raised to $647 from $458 at Truist » 09:05
06/14/21
06/14
09:05
06/14/21
09:05
BIIB

Biogen

$396.46 /

-18.29 (-4.41%)

Truist analyst Robyn…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIIB Biogen
$396.46 /

-18.29 (-4.41%)

BIIB Biogen
$396.46 /

-18.29 (-4.41%)

07:17 Today Goldman Sachs
Eli Lilly price target raised to $270 from $252 at Goldman Sachs
07:14 Today Goldman Sachs
Biogen price target raised to $436 from $246 at Goldman Sachs
06/11/21
Fly Intel: Top five analyst upgrades
06/11/21 Bernstein
Biogen upgraded to Outperform from Market Perform at Bernstein
BIIB Biogen
$396.46 /

-18.29 (-4.41%)

BIIB Biogen
$396.46 /

-18.29 (-4.41%)

BIIB Biogen
$396.46 /

-18.29 (-4.41%)

BIIB Biogen
$396.46 /

-18.29 (-4.41%)

Conference/Events
Broadcom management to meet virtually with KeyBanc » 09:05
06/14/21
06/14
09:05
06/14/21
09:05
AVGO

Broadcom

$470.68 /

+1.95 (+0.42%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVGO Broadcom
$470.68 /

+1.95 (+0.42%)

AVGO Broadcom
$470.68 /

+1.95 (+0.42%)

06/07/21 Baird
Broadcom price target raised to $550 from $500 at Baird
06/07/21 Baird
Broadcom price target raised to $550 from $500 at Baird
06/04/21 Morgan Stanley
Broadcom price target raised to $555 from $538 at Morgan Stanley
06/04/21 Wells Fargo
Broadcom price target raised to $475 from $450 at Wells Fargo
AVGO Broadcom
$470.68 /

+1.95 (+0.42%)

AVGO Broadcom
$470.68 /

+1.95 (+0.42%)

AVGO Broadcom
$470.68 /

+1.95 (+0.42%)

AVGO Broadcom
$470.68 /

+1.95 (+0.42%)

Hot Stocks
Franklin Electric appoints Jeffery Taylor as Vice President, CFO » 09:05
06/14/21
06/14
09:05
06/14/21
09:05
FELE

Franklin Electric

$80.82 /

+0.17 (+0.21%)

, BLBD

Blue Bird

$25.56 /

+0.095 (+0.37%)

Franklin Electric (FELE)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FELE Franklin Electric
$80.82 /

+0.17 (+0.21%)

BLBD Blue Bird
$25.56 /

+0.095 (+0.37%)

FELE Franklin Electric
$80.82 /

+0.17 (+0.21%)

03/22/21 DA Davidson
Franklin Electric price target raised to $75 from $70 at DA Davidson
09/29/20 Baird
Franklin Electric upgraded to Outperform at Baird
09/29/20 Baird
Franklin Electric upgraded to Outperform from Neutral at Baird
07/02/20
Fly Intel: Top five analyst downgrades
BLBD Blue Bird
$25.56 /

+0.095 (+0.37%)

05/13/21 Craig-Hallum
Blue Bird price target raised to $31 from $26 at Craig-Hallum
FELE Franklin Electric
$80.82 /

+0.17 (+0.21%)

BLBD Blue Bird
$25.56 /

+0.095 (+0.37%)

BLBD Blue Bird
$25.56 /

+0.095 (+0.37%)

BLBD Blue Bird
$25.56 /

+0.095 (+0.37%)

Syndicate
Synaptogenix announces $12.5M private placement » 09:03
06/14/21
06/14
09:03
06/14/21
09:03
SNPX

Synaptogenix

$7.90 /

-0.115 (-1.43%)

Synaptogenix announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Usio announces uplisting to Nasdaq Global Market » 09:03
06/14/21
06/14
09:03
06/14/21
09:03
USIO

Usio

$6.45 /

-0.01 (-0.15%)

Usio announced that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
USIO Usio
$6.45 /

-0.01 (-0.15%)

USIO Usio
$6.45 /

-0.01 (-0.15%)

03/30/21 Alliance Global Partners
Usio's Q4 gross margin not sustainable, says Alliance Global Partners
02/16/21 Alliance Global Partners
Usio shares 'over-bought' after 320% rally, says Alliance Global Partners
08/03/20 Alliance Global Partners
Alliance Global Partners downgrades Usio to Neutral, predicts 'weak' Q2 report
08/03/20 Alliance Global Partners
Usio downgraded to Neutral from Buy at Alliance Global Partners
USIO Usio
$6.45 /

-0.01 (-0.15%)

  • 23
    Sep
USIO Usio
$6.45 /

-0.01 (-0.15%)

USIO Usio
$6.45 /

-0.01 (-0.15%)

Syndicate
Recon Technology prices $55M registered direct offering » 09:01
06/14/21
06/14
09:01
06/14/21
09:01
RCON

Recon Technology

$6.23 /

-6.34 (-50.44%)

Recon Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RCON Recon Technology
$6.23 /

-6.34 (-50.44%)

Hot Stocks
DoorDash announces partnership with PetSmart » 09:01
06/14/21
06/14
09:01
06/14/21
09:01
DASH

DoorDash

$154.18 /

+9.475 (+6.55%)

DoorDash announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DASH DoorDash
$154.18 /

+9.475 (+6.55%)

DASH DoorDash
$154.18 /

+9.475 (+6.55%)

05/26/21 RBC Capital
DoorDash assumed with an Outperform at RBC Capital
05/20/21 DA Davidson
DoorDash price target lowered to $158 from $162 at DA Davidson
05/14/21
Fly Intel: Top five analyst upgrades
05/14/21 Wells Fargo
DoorDash upgraded to Overweight from Equal Weight at Wells Fargo
DASH DoorDash
$154.18 /

+9.475 (+6.55%)

  • 20
    May
  • 09
    Dec
DASH DoorDash
$154.18 /

+9.475 (+6.55%)

DASH DoorDash
$154.18 /

+9.475 (+6.55%)

DASH DoorDash
$154.18 /

+9.475 (+6.55%)

Hot Stocks
NFI Group receives order for 20 fuel cell-electric buses from AC Transit » 09:00
06/14/21
06/14
09:00
06/14/21
09:00
NFYEF

NFI Group

$21.85 /

-0.37 (-1.67%)

NFI Group announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFYEF NFI Group
$21.85 /

-0.37 (-1.67%)

NFYEF NFI Group
$21.85 /

-0.37 (-1.67%)

05/10/21 TD Securities
NFI Group price target lowered to C$33 from C$34 at TD Securities
03/05/21 National Bank
NFI Group price target raised to C$34 from C$32 at National Bank
03/05/21 BMO Capital
NFI Group price target lowered to C$38 from C$40 at BMO Capital
03/05/21 Scotiabank
NFI Group price target raised to C$35 from C$34 at Scotiabank
Hot Stocks
Hims & Hers to acquire Honest Health, terms undisclosed » 08:59
06/14/21
06/14
08:59
06/14/21
08:59
HIMS

Hims & Hers

$12.19 /

-0.645 (-5.03%)

Hims & Hers announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HIMS Hims & Hers
$12.19 /

-0.645 (-5.03%)

HIMS Hims & Hers
$12.19 /

-0.645 (-5.03%)

06/08/21 Piper Sandler
New Amazon offering targets Hims & Hers and others, says Piper Sandler
05/20/21 Credit Suisse
Hims & Hers upgraded to Outperform from Neutral at Credit Suisse
05/19/21 Citi
Hims & Hers price target lowered to $16 from $20 at Citi
05/19/21 Piper Sandler
Hims & Hers price target lowered to $11 from $18 at Piper Sandler
HIMS Hims & Hers
$12.19 /

-0.645 (-5.03%)

HIMS Hims & Hers
$12.19 /

-0.645 (-5.03%)

HIMS Hims & Hers
$12.19 /

-0.645 (-5.03%)

HIMS Hims & Hers
$12.19 /

-0.645 (-5.03%)

Downgrade
Range Resources downgraded to Hold from Buy at Tudor Pickering » 08:58
06/14/21
06/14
08:58
06/14/21
08:58
RRC

Range Resources

$16.02 /

+0.595 (+3.86%)

Tudor Pickering analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RRC Range Resources
$16.02 /

+0.595 (+3.86%)

RRC Range Resources
$16.02 /

+0.595 (+3.86%)

06/10/21 MKM Partners
Range Resources downgraded to Neutral at MKM Partners on valuation
06/10/21 RBC Capital
Range Resources upgraded to Outperform from Sector Perform at RBC Capital
06/10/21 MKM Partners
Range Resources downgraded to Neutral from Buy at MKM Partners
04/23/21 Raymond James
Range Resources downgraded to Underperform on valuation at Raymond James
RRC Range Resources
$16.02 /

+0.595 (+3.86%)

RRC Range Resources
$16.02 /

+0.595 (+3.86%)

On The Fly
Fly Intel: Pre-market Movers » 08:57
06/14/21
06/14
08:57
06/14/21
08:57
NVAX

Novavax

$209.60 /

+5.03 (+2.46%)

, CANO

Cano Health

$14.73 /

+0.035 (+0.24%)

, ITOS

iTeos Therapeutics

$20.01 /

+0.11 (+0.55%)

, TWST

Twist Bioscience

$114.75 /

+2.95 (+2.64%)

, REGN

Regeneron

$525.71 /

-6.63 (-1.25%)

, CODA

Coda Octopus Group

$9.15 /

+0.32 (+3.62%)

, MRNA

Moderna

$218.69 /

+1.59 (+0.73%)

, RACE

Ferrari

$211.19 /

-0.06 (-0.03%)

, RIDE

Lordstown Motors

$11.40 /

+0.795 (+7.50%)

, EXEL

Exelixis

$22.98 /

+0.01 (+0.04%)

, PHG

Philips

$56.52 /

-0.515 (-0.90%)

Check out this morning's…

ShowHide Related Items >><<
NVAX Novavax
$209.60 /

+5.03 (+2.46%)

CANO Cano Health
$14.73 /

+0.035 (+0.24%)

ITOS iTeos Therapeutics
$20.01 /

+0.11 (+0.55%)

TWST Twist Bioscience
$114.75 /

+2.95 (+2.64%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

MRNA Moderna
$218.69 /

+1.59 (+0.73%)

RACE Ferrari
$211.19 /

-0.06 (-0.03%)

RIDE Lordstown Motors
$11.40 /

+0.795 (+7.50%)

EXEL Exelixis
$22.98 /

+0.01 (+0.04%)

PHG Philips
$56.52 /

-0.515 (-0.90%)

NVAX Novavax
$209.60 /

+5.03 (+2.46%)

06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
05/12/21 B. Riley
Novavax price target lowered to $286 from $365 at B. Riley
05/12/21 Cantor Fitzgerald
Novavax price target lowered to $217 from $338 at Cantor Fitzgerald
CANO Cano Health
$14.73 /

+0.035 (+0.24%)

11/19/20 Compass Point
Compass Point upgrades PennantPark to Buy after Cano Health 'game changer'
ITOS iTeos Therapeutics
$20.01 /

+0.11 (+0.55%)

05/19/21 SVB Leerink
iTeos Therapeutics price target lowered to $45 from $60 at SVB Leerink
05/14/21 Piper Sandler
iTeos Therapeutics recent pullback unwarranted, says Piper Sandler
05/05/21 H.C. Wainwright
iTeos Therapeutics initiated with a Buy at H.C. Wainwright
04/12/21 Piper Sandler
iTeos Therapeutics' EOS-448 'competitive' in TIGIT class, says Piper Sandler
TWST Twist Bioscience
$114.75 /

+2.95 (+2.64%)

06/04/21
Fly Intel: Top five analyst initiations
06/04/21 Goldman Sachs
Twist Bioscience initiated with a Neutral at Goldman Sachs
05/11/21 Piper Sandler
Twist Bioscience recent weakness a buying opportunity, says Piper Sandler
04/12/21
Fly Intel: Top five analyst initiations
REGN Regeneron
$525.71 /

-6.63 (-1.25%)

07:32 Today Argus
Regeneron's multiple bullish signals suggest return to growth, says Argus
05/13/21 Needham
Graybug Vision downgraded to Hold from Buy at Needham
05/07/21 Morgan Stanley
Regeneron price target raised to $495 from $477 at Morgan Stanley
05/06/21 Piper Sandler
Regeneron remains top large cap pick, says Piper Sandler
CODA Coda Octopus Group
$9.15 /

+0.32 (+3.62%)

MRNA Moderna
$218.69 /

+1.59 (+0.73%)

06/10/21 Piper Sandler
Moderna should be vaccinating teens this summer, says Piper Sandler
06/07/21 Piper Sandler
Moderna price target raised to $246 from $231 at Piper Sandler
05/21/21 Piper Sandler
Piper says overseas approvals providing 'second leg of growth' for Moderna
05/07/21 Barclays
Moderna price target raised to $194 from $178 at Barclays
RACE Ferrari
$211.19 /

-0.06 (-0.03%)

06/13/21 Goldman Sachs
Ferrari downgraded to Sell from Buy at Goldman Sachs
05/19/21 Redburn
Redburn downgrades Ferrari on free cash flow margin concerns
05/19/21 Redburn
Ferrari downgraded to Neutral from Buy at Redburn
05/06/21 RBC Capital
Ferrari price target lowered to EUR 202 from EUR 204 at RBC Capital
RIDE Lordstown Motors
$11.40 /

+0.795 (+7.50%)

06/10/21 Morgan Stanley
Morgan Stanley removes Lordstown rating, says market may be underestimating risk
06/08/21 RBC Capital
Lordstown Motors initiated with an Underperform at RBC Capital
05/28/21
Fly Intel: Top five analyst initiations
05/28/21 Deutsche Bank
Deutsche starts Lordstown with Hold on 'considerable uncertainty'
EXEL Exelixis
$22.98 /

+0.01 (+0.04%)

05/25/21 Stifel
Exelixis' COSMIC-021 cohort 6 results 'incrementally negative,' says Stifel
05/18/21 Goldman Sachs
Exelixis assumed with a Sell at Goldman Sachs
03/30/21 Credit Suisse
Exelixis initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Exelixis initiated with an Outperform at Credit Suisse
PHG Philips
$56.52 /

-0.515 (-0.90%)

04/29/21 Berenberg
Philips price target raised to EUR 52 from EUR 50 at Berenberg
04/28/21 Credit Suisse
Philips price target raised to EUR 49 from EUR 45 at Credit Suisse
04/27/21 UBS
Philips price target raised to EUR 56 from EUR 54 at UBS
03/23/21 Barclays
Philips price target raised to EUR 55 from EUR 54 at Barclays
NVAX Novavax
$209.60 /

+5.03 (+2.46%)

CANO Cano Health
$14.73 /

+0.035 (+0.24%)

ITOS iTeos Therapeutics
$20.01 /

+0.11 (+0.55%)

TWST Twist Bioscience
$114.75 /

+2.95 (+2.64%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

CODA Coda Octopus Group
$9.15 /

+0.32 (+3.62%)

MRNA Moderna
$218.69 /

+1.59 (+0.73%)

RACE Ferrari
$211.19 /

-0.06 (-0.03%)

RIDE Lordstown Motors
$11.40 /

+0.795 (+7.50%)

EXEL Exelixis
$22.98 /

+0.01 (+0.04%)

PHG Philips
$56.52 /

-0.515 (-0.90%)

  • 03
    Dec
  • 24
    Jul
NVAX Novavax
$209.60 /

+5.03 (+2.46%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

MRNA Moderna
$218.69 /

+1.59 (+0.73%)

RIDE Lordstown Motors
$11.40 /

+0.795 (+7.50%)

PHG Philips
$56.52 /

-0.515 (-0.90%)

NVAX Novavax
$209.60 /

+5.03 (+2.46%)

TWST Twist Bioscience
$114.75 /

+2.95 (+2.64%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

MRNA Moderna
$218.69 /

+1.59 (+0.73%)

RIDE Lordstown Motors
$11.40 /

+0.795 (+7.50%)

EXEL Exelixis
$22.98 /

+0.01 (+0.04%)

PHG Philips
$56.52 /

-0.515 (-0.90%)

NVAX Novavax
$209.60 /

+5.03 (+2.46%)

CANO Cano Health
$14.73 /

+0.035 (+0.24%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

MRNA Moderna
$218.69 /

+1.59 (+0.73%)

RIDE Lordstown Motors
$11.40 /

+0.795 (+7.50%)

Options
Notable open interest changes for June 14th » 08:55
06/14/21
06/14
08:55
06/14/21
08:55
NIO

Nio

$45.69 /

+2.94 (+6.88%)

, AAPL

Apple

$127.36 /

+1.26 (+1.00%)

, AMC

AMC Entertainment

$49.32 /

+6.435 (+15.01%)

, SNAP

Snap

$64.11 /

+1.415 (+2.26%)

Friday's total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NIO Nio
$45.69 /

+2.94 (+6.88%)

AAPL Apple
$127.36 /

+1.26 (+1.00%)

AMC AMC Entertainment
$49.32 /

+6.435 (+15.01%)

SNAP Snap
$64.11 /

+1.415 (+2.26%)

NIO Nio
$45.69 /

+2.94 (+6.88%)

06/08/21 Bocom
Nio initiated with a Buy at Bocom
06/07/21 Wedbush
Wedbush remains 'firmly bullish' on Tesla, EV thesis despite speed bumps
06/01/21
Fly Intel: Top five analyst upgrades
06/01/21 Citi
Nio upgraded to Buy from Neutral at Citi
AAPL Apple
$127.36 /

+1.26 (+1.00%)

06/11/21 Argus
Apple underperformance due to sector rotation, not misfires, says Argus
06/08/21 RBC Capital
Fisker initiated with an Outperform at RBC Capital
06/08/21 BofA
Apple App store growth decelerating in Q3 to-date, says BofA
06/08/21 Wedbush
Apple WWDC 'all about iOS 15, new Macs,' says Wedbush
AMC AMC Entertainment
$49.32 /

+6.435 (+15.01%)

06/08/21 MKM Partners
AMC Entertainment shareholders best served by lower debt, says MKM Partners
06/07/21 B. Riley
Box office trends improving into summer, says B. Riley
06/04/21 BofA
BofA moves to No Rating on Bed Bath & Beyond amid 'meme mania'
06/04/21 Wedbush
AMC Entertainment price target raised to $7.50 from $6.50 at Wedbush
SNAP Snap
$64.11 /

+1.415 (+2.26%)

06/02/21 Cowen
Poshmark pent up demand for apparel should bode well, says Cowen
05/21/21 Piper Sandler
Snap remains top pick in social advertising at Piper Sandler
05/10/21 Citi
Snap price target lowered to $42 from $47 at Citi
05/04/21 Citi
Snap price target raised to $47 from $40 at Citi
NIO Nio
$45.69 /

+2.94 (+6.88%)

AAPL Apple
$127.36 /

+1.26 (+1.00%)

AMC AMC Entertainment
$49.32 /

+6.435 (+15.01%)

SNAP Snap
$64.11 /

+1.415 (+2.26%)

  • 14
    Dec
  • 31
    Aug
NIO Nio
$45.69 /

+2.94 (+6.88%)

AAPL Apple
$127.36 /

+1.26 (+1.00%)

AMC AMC Entertainment
$49.32 /

+6.435 (+15.01%)

SNAP Snap
$64.11 /

+1.415 (+2.26%)

NIO Nio
$45.69 /

+2.94 (+6.88%)

AAPL Apple
$127.36 /

+1.26 (+1.00%)

AMC AMC Entertainment
$49.32 /

+6.435 (+15.01%)

SNAP Snap
$64.11 /

+1.415 (+2.26%)

NIO Nio
$45.69 /

+2.94 (+6.88%)

AAPL Apple
$127.36 /

+1.26 (+1.00%)

AMC AMC Entertainment
$49.32 /

+6.435 (+15.01%)

SNAP Snap
$64.11 /

+1.415 (+2.26%)

Hot Stocks
Columbus McKinnon appoints Adrienne Williams as Chief Human Resources Officer » 08:54
06/14/21
06/14
08:54
06/14/21
08:54
CMCO

Columbus McKinnon

$49.51 /

+0.11 (+0.22%)

Columbus McKinnon …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMCO Columbus McKinnon
$49.51 /

+0.11 (+0.22%)

CMCO Columbus McKinnon
$49.51 /

+0.11 (+0.22%)

05/26/21 Barrington
Columbus McKinnon price target raised to $78 from $67 at Barrington
05/03/21 Wells Fargo
Columbus McKinnon initiated with an Overweight at Wells Fargo
03/02/21 Barrington
Columbus McKinnon price target raised to $67 from $56 at Barrington
02/26/21 DA Davidson
Columbus McKinnon upgraded to Buy from Neutral at DA Davidson
CMCO Columbus McKinnon
$49.51 /

+0.11 (+0.22%)

  • 30
    Apr
Hot Stocks
Avalon GloboCare Corporation trading halted, news pending  08:54
06/14/21
06/14
08:54
06/14/21
08:54
AVCO

Avalon GloboCare

$1.23 /

+0.025 (+2.08%)

 
ShowHide Related Items >><<
AVCO Avalon GloboCare
$1.23 /

+0.025 (+2.08%)

Hot Stocks
Altus Group reports cybersecurity incident » 08:53
06/14/21
06/14
08:53
06/14/21
08:53
ASGTF

Altus Group

$47.92 /

+ (+0.00%)

Altus Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASGTF Altus Group
$47.92 /

+ (+0.00%)

ASGTF Altus Group
$47.92 /

+ (+0.00%)

05/07/21 RBC Capital
Altus Group price target raised to C$68 from C$62 at RBC Capital
05/07/21 CIBC
Altus Group price target raised to C$58 from C$52.50 at CIBC
04/22/21 Canaccord
Altus Group price target raised to C$70 from C$59 at Canaccord
03/10/21 BMO Capital
Altus Group price target raised to C$66 from C$63 at BMO Capital
Hot Stocks
Charles Schwab reports total client assets were $7.4T as of month-end May » 08:51
06/14/21
06/14
08:51
06/14/21
08:51
SCHW

Charles Schwab

$73.92 /

+1.34 (+1.85%)

The Charles Schwab…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCHW Charles Schwab
$73.92 /

+1.34 (+1.85%)

SCHW Charles Schwab
$73.92 /

+1.34 (+1.85%)

06/10/21 Citi
Virtu, Charles Schwab selloffs on SEC comments overdone, says Citi
06/02/21 Wells Fargo
Charles Schwab price target raised to $88 from $76 at Wells Fargo
05/13/21 JPMorgan
Charles Schwab price target raised to $84 from $82 at JPMorgan
04/27/21
Fly Intel: Top five analyst upgrades
SCHW Charles Schwab
$73.92 /

+1.34 (+1.85%)

SCHW Charles Schwab
$73.92 /

+1.34 (+1.85%)

SCHW Charles Schwab
$73.92 /

+1.34 (+1.85%)

SCHW Charles Schwab
$73.92 /

+1.34 (+1.85%)

Syndicate
OncoCyte enters at-the-market sale for $50M in common stock » 08:50
06/14/21
06/14
08:50
06/14/21
08:50
OCX

OncoCyte

$5.45 /

+0.225 (+4.31%)

In an 8-K filing the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OCX OncoCyte
$5.45 /

+0.225 (+4.31%)

OCX OncoCyte
$5.45 /

+0.225 (+4.31%)

04/12/21 Lake Street
AACR data strengthens 'pan-cancer credentials' for OncoCyte, says Lake Street
04/12/21 Piper Sandler
OncoCyte remains a top pick small-cap pick at Piper Sandler
03/30/21 Piper Sandler
OncoCyte called 'top small-cap pick' at Piper Sandler
03/17/21
Fly Intel: Top five analyst initiations
OCX OncoCyte
$5.45 /

+0.225 (+4.31%)

  • 05
    Feb
OCX OncoCyte
$5.45 /

+0.225 (+4.31%)

General news
Oil Action: WTI crude » 08:50
06/14/21
06/14
08:50
06/14/21
08:50
$ECON

Economic Data

/

+

Oil Action: WTI crude hit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

Recommendations
RadNet price target raised to $40 from $30 at Sidoti » 08:47
06/14/21
06/14
08:47
06/14/21
08:47
RDNT

RadNet

$31.26 /

-0.03 (-0.10%)

Sidoti analyst Mitra…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDNT RadNet
$31.26 /

-0.03 (-0.10%)

RDNT RadNet
$31.26 /

-0.03 (-0.10%)

06/09/21 Clarus
Akumin valuation gap to RadNet has become 'excessive,' says Clarus
06/07/21 Jefferies
Approval of Biogen Alzheimer's drug could be catalyst for RadNet, says Jefferies
09/03/20 Clarus
Akumin can re-rate as Nasdaq listing raises U.S. awareness, says Clarus
RDNT RadNet
$31.26 /

-0.03 (-0.10%)

Recommendations
Vertex Pharmaceuticals price target lowered to $200 from $250 at SVB Leerink » 08:46
06/14/21
06/14
08:46
06/14/21
08:46
VRTX

Vertex Pharmaceuticals

$193.02 /

-23.93 (-11.03%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

06:04 Today Deutsche Bank
Grifols upgraded to Buy from Hold at Deutsche Bank
06/13/21 Piper Sandler
Vertex Pharmaceuticals price target lowered to $261 from $347 at Piper Sandler
06/11/21 Roth Capital
Crispr Therapeutics reported 'robust' sickle cell data, says Roth Capital
06/11/21
Fly Intel: Top five analyst downgrades
VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

Hot Stocks
Akamai names Dr. Boaz Gelbord as Chief Security Officer » 08:45
06/14/21
06/14
08:45
06/14/21
08:45
AKAM

Akamai

$118.46 /

-0.69 (-0.58%)

Akamai Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKAM Akamai
$118.46 /

-0.69 (-0.58%)

AKAM Akamai
$118.46 /

-0.69 (-0.58%)

05/20/21 Piper Sandler
Akamai price target raised to $130 from $121 at Piper Sandler
05/05/21 KeyBanc
Akamai price target raised to $130 from $119 at KeyBanc
04/26/21 Piper Sandler
Akamai moving higher on activist speculation, says Piper Sandler
03/15/21 Credit Suisse
Akamai assumed with a Neutral at Credit Suisse
AKAM Akamai
$118.46 /

-0.69 (-0.58%)

AKAM Akamai
$118.46 /

-0.69 (-0.58%)

AKAM Akamai
$118.46 /

-0.69 (-0.58%)

AKAM Akamai
$118.46 /

-0.69 (-0.58%)

Options
Largest borrow rate increases among liquid names » 08:45
06/14/21
06/14
08:45
06/14/21
08:45
ARVL

Arrival

$19.20 /

-0.555 (-2.81%)

, UPST

Upstart

$125.55 /

-20.89 (-14.27%)

, HTZGQ

Hertz

$1.79 /

+ (+0.00%)

, IPOF

Social Capital Hedosophia Holdings Corp. VI

$10.33 /

+0.045 (+0.44%)

, ATER

Aterian

$15.81 /

+0.14 (+0.89%)

, PRPO

Precipio

$3.84 /

+0.04 (+1.05%)

, CLII

Climate Change Crisis Real Impact I

$13.70 /

-0.05 (-0.36%)

, SPI

SPI Energy

$6.95 /

-0.32 (-4.40%)

, LHDX

Lucira Health

$5.59 /

+0.29 (+5.47%)

, BNGO

Bionano Genomics

$7.57 /

-0.075 (-0.98%)

Latest data shows the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARVL Arrival
$19.20 /

-0.555 (-2.81%)

UPST Upstart
$125.55 /

-20.89 (-14.27%)

HTZGQ Hertz
$1.79 /

+ (+0.00%)

IPOF Social Capital Hedosophia Holdings Corp. VI
$10.33 /

+0.045 (+0.44%)

ATER Aterian
$15.81 /

+0.14 (+0.89%)

PRPO Precipio
$3.84 /

+0.04 (+1.05%)

CLII Climate Change Crisis Real Impact I
$13.70 /

-0.05 (-0.36%)

SPI SPI Energy
$6.95 /

-0.32 (-4.40%)

LHDX Lucira Health
$5.59 /

+0.29 (+5.47%)

BNGO Bionano Genomics
$7.57 /

-0.075 (-0.98%)

ARVL Arrival
$19.20 /

-0.555 (-2.81%)

06/03/21 Barclays
Arrival initiated with an Overweight at Barclays
04/05/21 Cowen
Cowen starts Arrival at Outperform on 'unique microfactory approach'
04/05/21 Cowen
Arrival initiated with an Outperform at Cowen
UPST Upstart
$125.55 /

-20.89 (-14.27%)

05/12/21 JMP Securities
Upstart price target raised to $149 from $111 at JMP Securities
05/12/21 Piper Sandler
Upstart price target raised to $152 from $143 at Piper Sandler
04/27/21
Fly Intel: Top five analyst initiations
04/27/21 Piper Sandler
Upstart initiated with an Overweight at Piper Sandler
HTZGQ Hertz
$1.79 /

+ (+0.00%)

IPOF Social Capital Hedosophia Holdings Corp. VI
$10.33 /

+0.045 (+0.44%)

ATER Aterian
$15.81 /

+0.14 (+0.89%)

05/07/21 Alliance Global Partners
Alliance Global says Aterian stock oversold, calls a top pick after recent drop
05/05/21 Roth Capital
Aterian price target lowered to $30 from $40 at Roth Capital
PRPO Precipio
$3.84 /

+0.04 (+1.05%)

04/01/21 Maxim
Precipio price target raised to $7 from $2 at Maxim
CLII Climate Change Crisis Real Impact I
$13.70 /

-0.05 (-0.36%)

SPI SPI Energy
$6.95 /

-0.32 (-4.40%)

LHDX Lucira Health
$5.59 /

+0.29 (+5.47%)

05/04/21 William Blair
William Blair downgrades Lucira Health on slowing Covid testing volumes
05/04/21 William Blair
Lucira Health downgraded to Market Perform from Outperform at William Blair
04/13/21
Fly Intel: Top five analyst downgrades
04/13/21 BofA
Lucira Health downgraded to Underperform from Buy at BofA
BNGO Bionano Genomics
$7.57 /

-0.075 (-0.98%)

02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
12/04/20 Roth Capital
Bionano Genomics downgraded to Neutral from Buy at Roth Capital
UPST Upstart
$125.55 /

-20.89 (-14.27%)

HTZGQ Hertz
$1.79 /

+ (+0.00%)

PRPO Precipio
$3.84 /

+0.04 (+1.05%)

LHDX Lucira Health
$5.59 /

+0.29 (+5.47%)

BNGO Bionano Genomics
$7.57 /

-0.075 (-0.98%)

  • 09
    Apr
  • 05
    Feb
  • 20
    Jan
  • 08
    Jan
  • 16
    Dec
  • 01
    Oct
ARVL Arrival
$19.20 /

-0.555 (-2.81%)

HTZGQ Hertz
$1.79 /

+ (+0.00%)

IPOF Social Capital Hedosophia Holdings Corp. VI
$10.33 /

+0.045 (+0.44%)

CLII Climate Change Crisis Real Impact I
$13.70 /

-0.05 (-0.36%)

ARVL Arrival
$19.20 /

-0.555 (-2.81%)

UPST Upstart
$125.55 /

-20.89 (-14.27%)

IPOF Social Capital Hedosophia Holdings Corp. VI
$10.33 /

+0.045 (+0.44%)

CLII Climate Change Crisis Real Impact I
$13.70 /

-0.05 (-0.36%)

SPI SPI Energy
$6.95 /

-0.32 (-4.40%)

LHDX Lucira Health
$5.59 /

+0.29 (+5.47%)

BNGO Bionano Genomics
$7.57 /

-0.075 (-0.98%)

ARVL Arrival
$19.20 /

-0.555 (-2.81%)

UPST Upstart
$125.55 /

-20.89 (-14.27%)

HTZGQ Hertz
$1.79 /

+ (+0.00%)

IPOF Social Capital Hedosophia Holdings Corp. VI
$10.33 /

+0.045 (+0.44%)

ATER Aterian
$15.81 /

+0.14 (+0.89%)

PRPO Precipio
$3.84 /

+0.04 (+1.05%)

CLII Climate Change Crisis Real Impact I
$13.70 /

-0.05 (-0.36%)

SPI SPI Energy
$6.95 /

-0.32 (-4.40%)

LHDX Lucira Health
$5.59 /

+0.29 (+5.47%)

BNGO Bionano Genomics
$7.57 /

-0.075 (-0.98%)

Recommendations
Ascendis Pharma price target lowered to $181 from $191 at SVB Leerink » 08:44
06/14/21
06/14
08:44
06/14/21
08:44
ASND

Ascendis Pharma

$130.26 /

+1.7 (+1.32%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASND Ascendis Pharma
$130.26 /

+1.7 (+1.32%)

ASND Ascendis Pharma
$130.26 /

+1.7 (+1.32%)

08:29 Today Canaccord
Ascendis Pharma PDUFA extension an encouraging sign, says Canaccord
07:52 Today Wedbush
Ascendis Pharma price target lowered to $189 from $219 at Wedbush
07:10 Today Cantor Fitzgerald
Ascendis's TransCon GH still likely to gain approval, says Cantor Fitzgerald
06:28 Today Morgan Stanley
Ascendis Pharma price target lowered to $197 from $201 at Morgan Stanley
ASND Ascendis Pharma
$130.26 /

+1.7 (+1.32%)

  • 08
    Jul
Hot Stocks
Anavex reports new publication in medical journal on ANAVEX 2-73, ANAVEX 3-71 » 08:43
06/14/21
06/14
08:43
06/14/21
08:43
AVXL

Anavex

$15.51 /

+0.09 (+0.58%)

Anavex Life Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVXL Anavex
$15.51 /

+0.09 (+0.58%)

AVXL Anavex
$15.51 /

+0.09 (+0.58%)

02/24/21 Cantor Fitzgerald
Anavex price target raised to $25 from $10 at Cantor Fitzgerald
02/23/21 Cantor Fitzgerald
Anavex price target raised to $25 from $10 at Cantor Fitzgerald
12/29/20 Cantor Fitzgerald
Anavex cash position to fund operations into 2022, says Cantor Fitzgerald
12/16/20 H.C. Wainwright
Anavex price target raised to $17 from $14 at H.C. Wainwright
AVXL Anavex
$15.51 /

+0.09 (+0.58%)

AVXL Anavex
$15.51 /

+0.09 (+0.58%)

Recommendations
BeiGene price target raised to $417 from $388 at SVB Leerink » 08:42
06/14/21
06/14
08:42
06/14/21
08:42
BGNE

BeiGene

$346.81 /

-6.09 (-1.73%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

  • 02
    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.